Credit Agricole’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $344K | Sell |
4,871
-1,032
| -17% | -$73K | ﹤0.01% | 962 |
|
|
2024
Q4 | $388K | Sell |
5,903
-225
| -4% | -$14.8K | ﹤0.01% | 979 |
|
|
2024
Q3 | $431K | Buy |
6,128
+688
| +13% | +$48.4K | ﹤0.01% | 881 |
|
|
2024
Q2 | $448K | Buy |
5,440
+4,090
| +303% | +$337K | ﹤0.01% | 773 |
|
|
2024
Q1 | $122K | Sell |
1,350
-10
| -0.7% | -$901 | ﹤0.01% | 667 |
|
|
2023
Q4 | $131K | Sell |
1,360
-105
| -7% | -$10.1K | ﹤0.01% | 638 |
|
|
2023
Q3 | $130K | Sell |
1,465
-231
| -14% | -$20.4K | ﹤0.01% | 581 |
|
|
2023
Q2 | $147K | Buy |
1,696
+696
| +70% | +$60.3K | ﹤0.01% | 360 |
|
|
2023
Q1 | $97.2K | Hold |
1,000
| – | – | ﹤0.01% | 371 |
|
|
2022
Q4 | $103K | Hold |
1,000
| – | – | ﹤0.01% | 367 |
|
|
2022
Q3 | $85K | Hold |
1,000
| – | – | ﹤0.01% | 387 |
|
|
2022
Q2 | $83K | Hold |
1,000
| – | – | ﹤0.01% | 387 |
|
|
2022
Q1 | $77K | Hold |
1,000
| – | – | ﹤0.01% | 424 |
|
|
2021
Q4 | $88K | Hold |
1,000
| – | – | ﹤0.01% | 414 |
|
|
2021
Q3 | $77K | Sell |
1,000
-1,400
| -58% | -$108K | ﹤0.01% | 393 |
|
|
2021
Q2 | $200K | Hold |
2,400
| – | – | ﹤0.01% | 303 |
|
|
2021
Q1 | $181K | Buy |
2,400
+1,200
| +100% | +$90.5K | ﹤0.01% | 296 |
|
|
2020
Q4 | $105K | Hold |
1,200
| – | – | ﹤0.01% | 303 |
|
|
2020
Q3 | $91K | Hold |
1,200
| – | – | ﹤0.01% | 298 |
|
|
2020
Q2 | $148K | Hold |
1,200
| – | – | 0.01% | 242 |
|
|
2020
Q1 | $101K | Hold |
1,200
| – | – | 0.01% | 257 |
|
|
2019
Q4 | $101K | Hold |
1,200
| – | – | 0.01% | 262 |
|
|
2019
Q3 | $81K | Hold |
1,200
| – | – | ﹤0.01% | 344 |
|
|
2019
Q2 | $103K | Hold |
1,200
| – | – | 0.01% | 326 |
|
|
2019
Q1 | $107K | Buy |
1,200
+200
| +20% | +$17.8K | 0.01% | 338 |
|
|
2018
Q4 | $85K | Hold |
1,000
| – | – | ﹤0.01% | 361 |
|
|
2018
Q3 | $97K | Hold |
1,000
| – | – | ﹤0.01% | 348 |
|
|
2018
Q2 | $94K | Buy |
+1,000
| New | +$94K | 0.01% | 319 |
|
|
2017
Q4 | – | Sell |
-169,520
| Closed | -$15.8M | – | 458 |
|
|
2017
Q3 | $15.8M | Buy |
169,520
+36,712
| +28% | +$3.42M | 0.05% | 350 |
|
|
2017
Q2 | $12.1M | Buy |
132,808
+47,873
| +56% | +$4.35M | 0.04% | 439 |
|
|
2017
Q1 | $7.46M | Sell |
84,935
-20,628
| -20% | -$1.81M | 0.02% | 638 |
|
|
2016
Q4 | $8.74M | Buy |
105,563
+73,246
| +227% | +$6.07M | 0.03% | 531 |
|
|
2016
Q3 | $2.99M | Buy |
32,317
+8,298
| +35% | +$768K | 0.01% | 822 |
|
|
2016
Q2 | $1.87M | Buy |
24,019
+134
| +0.6% | +$10.4K | 0.01% | 851 |
|
|
2016
Q1 | $1.97M | Sell |
23,885
-1,308
| -5% | -$108K | 0.01% | 768 |
|
|
2015
Q4 | $2.64M | Sell |
25,193
-4,972
| -16% | -$521K | 0.01% | 731 |
|
|
2015
Q3 | $3.18M | Sell |
30,165
-2,100
| -7% | -$221K | 0.02% | 687 |
|
|
2015
Q2 | $4.41M | Sell |
32,265
-10,125
| -24% | -$1.38M | 0.02% | 621 |
|
|
2015
Q1 | $5.28M | Buy |
42,390
+12,477
| +42% | +$1.55M | 0.02% | 599 |
|
|
2014
Q4 | $2.81M | Buy |
29,913
+3,786
| +14% | +$355K | 0.01% | 799 |
|
|
2014
Q3 | $1.89M | Sell |
26,127
-3,106
| -11% | -$224K | 0.01% | 906 |
|
|
2014
Q2 | $1.82M | Sell |
29,233
-42,028
| -59% | -$2.61M | 0.01% | 948 |
|
|
2014
Q1 | $4.86M | Sell |
71,261
-3,184
| -4% | -$217K | 0.02% | 617 |
|
|
2013
Q4 | $5.24M | Sell |
74,445
-10,944
| -13% | -$770K | 0.02% | 593 |
|
|
2013
Q3 | $6.16M | Buy |
+85,389
| New | +$6.16M | 0.03% | 547 |
|